Global Split Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Split Influenza Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Split Influenza Vaccine industry chain, the market status of Hospital (Aldult, Child), Clinic (Aldult, Child), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Split Influenza Vaccine.

Regionally, the report analyzes the Split Influenza Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Split Influenza Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Split Influenza Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Split Influenza Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Aldult, Child).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Split Influenza Vaccine market.

Regional Analysis: The report involves examining the Split Influenza Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Split Influenza Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Split Influenza Vaccine:
Company Analysis: Report covers individual Split Influenza Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Split Influenza Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).

Technology Analysis: Report covers specific technologies relevant to Split Influenza Vaccine. It assesses the current state, advancements, and potential future developments in Split Influenza Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Split Influenza Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Split Influenza Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Aldult
    Child

Market segment by Application
    Hospital
    Clinic

Major players covered
    Sanofi Pasteur
    CSL Seqirus
    GSK
    Seqirus, Inc.
    straZeneca
    Dalian Yali Peak

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Split Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Split Influenza Vaccine, with price, sales, revenue and global market share of Split Influenza Vaccine from 2019 to 2024.
Chapter 3, the Split Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Split Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Split Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Split Influenza Vaccine.
Chapter 14 and 15, to describe Split Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Split Influenza Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Split Influenza Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Aldult
        1.3.3 Child
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Split Influenza Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
    1.5 Global Split Influenza Vaccine Market Size & Forecast
        1.5.1 Global Split Influenza Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Split Influenza Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Split Influenza Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Sanofi Pasteur
        2.1.1 Sanofi Pasteur Details
        2.1.2 Sanofi Pasteur Major Business
        2.1.3 Sanofi Pasteur Split Influenza Vaccine Product and Services
        2.1.4 Sanofi Pasteur Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Sanofi Pasteur Recent Developments/Updates
    2.2 CSL Seqirus
        2.2.1 CSL Seqirus Details
        2.2.2 CSL Seqirus Major Business
        2.2.3 CSL Seqirus Split Influenza Vaccine Product and Services
        2.2.4 CSL Seqirus Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 CSL Seqirus Recent Developments/Updates
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Split Influenza Vaccine Product and Services
        2.3.4 GSK Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 GSK Recent Developments/Updates
    2.4 Seqirus, Inc.
        2.4.1 Seqirus, Inc. Details
        2.4.2 Seqirus, Inc. Major Business
        2.4.3 Seqirus, Inc. Split Influenza Vaccine Product and Services
        2.4.4 Seqirus, Inc. Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Seqirus, Inc. Recent Developments/Updates
    2.5 straZeneca
        2.5.1 straZeneca Details
        2.5.2 straZeneca Major Business
        2.5.3 straZeneca Split Influenza Vaccine Product and Services
        2.5.4 straZeneca Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 straZeneca Recent Developments/Updates
    2.6 Dalian Yali Peak
        2.6.1 Dalian Yali Peak Details
        2.6.2 Dalian Yali Peak Major Business
        2.6.3 Dalian Yali Peak Split Influenza Vaccine Product and Services
        2.6.4 Dalian Yali Peak Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Dalian Yali Peak Recent Developments/Updates

3 Competitive Environment: Split Influenza Vaccine by Manufacturer
    3.1 Global Split Influenza Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Split Influenza Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Split Influenza Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Split Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Split Influenza Vaccine Manufacturer Market Share in 2023
        3.4.2 Top 6 Split Influenza Vaccine Manufacturer Market Share in 2023
    3.5 Split Influenza Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Split Influenza Vaccine Market: Region Footprint
        3.5.2 Split Influenza Vaccine Market: Company Product Type Footprint
        3.5.3 Split Influenza Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Split Influenza Vaccine Market Size by Region
        4.1.1 Global Split Influenza Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Split Influenza Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Split Influenza Vaccine Average Price by Region (2019-2030)
    4.2 North America Split Influenza Vaccine Consumption Value (2019-2030)
    4.3 Europe Split Influenza Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Split Influenza Vaccine Consumption Value (2019-2030)
    4.5 South America Split Influenza Vaccine Consumption Value (2019-2030)
    4.6 Middle East and Africa Split Influenza Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Split Influenza Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Split Influenza Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Split Influenza Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Split Influenza Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Split Influenza Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Split Influenza Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Split Influenza Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Split Influenza Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Split Influenza Vaccine Market Size by Country
        7.3.1 North America Split Influenza Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Split Influenza Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Split Influenza Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Split Influenza Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Split Influenza Vaccine Market Size by Country
        8.3.1 Europe Split Influenza Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Split Influenza Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Split Influenza Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Split Influenza Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Split Influenza Vaccine Market Size by Region
        9.3.1 Asia-Pacific Split Influenza Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Split Influenza Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Split Influenza Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Split Influenza Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Split Influenza Vaccine Market Size by Country
        10.3.1 South America Split Influenza Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Split Influenza Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Split Influenza Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Split Influenza Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Split Influenza Vaccine Market Size by Country
        11.3.1 Middle East & Africa Split Influenza Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Split Influenza Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Split Influenza Vaccine Market Drivers
    12.2 Split Influenza Vaccine Market Restraints
    12.3 Split Influenza Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Split Influenza Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Split Influenza Vaccine
    13.3 Split Influenza Vaccine Production Process
    13.4 Split Influenza Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Split Influenza Vaccine Typical Distributors
    14.3 Split Influenza Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Split Influenza Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Split Influenza Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Pasteur Major Business
    Table 5. Sanofi Pasteur Split Influenza Vaccine Product and Services
    Table 6. Sanofi Pasteur Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Sanofi Pasteur Recent Developments/Updates
    Table 8. CSL Seqirus Basic Information, Manufacturing Base and Competitors
    Table 9. CSL Seqirus Major Business
    Table 10. CSL Seqirus Split Influenza Vaccine Product and Services
    Table 11. CSL Seqirus Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. CSL Seqirus Recent Developments/Updates
    Table 13. GSK Basic Information, Manufacturing Base and Competitors
    Table 14. GSK Major Business
    Table 15. GSK Split Influenza Vaccine Product and Services
    Table 16. GSK Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. GSK Recent Developments/Updates
    Table 18. Seqirus, Inc. Basic Information, Manufacturing Base and Competitors
    Table 19. Seqirus, Inc. Major Business
    Table 20. Seqirus, Inc. Split Influenza Vaccine Product and Services
    Table 21. Seqirus, Inc. Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Seqirus, Inc. Recent Developments/Updates
    Table 23. straZeneca Basic Information, Manufacturing Base and Competitors
    Table 24. straZeneca Major Business
    Table 25. straZeneca Split Influenza Vaccine Product and Services
    Table 26. straZeneca Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. straZeneca Recent Developments/Updates
    Table 28. Dalian Yali Peak Basic Information, Manufacturing Base and Competitors
    Table 29. Dalian Yali Peak Major Business
    Table 30. Dalian Yali Peak Split Influenza Vaccine Product and Services
    Table 31. Dalian Yali Peak Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Dalian Yali Peak Recent Developments/Updates
    Table 33. Global Split Influenza Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 34. Global Split Influenza Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 35. Global Split Influenza Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 36. Market Position of Manufacturers in Split Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 37. Head Office and Split Influenza Vaccine Production Site of Key Manufacturer
    Table 38. Split Influenza Vaccine Market: Company Product Type Footprint
    Table 39. Split Influenza Vaccine Market: Company Product Application Footprint
    Table 40. Split Influenza Vaccine New Market Entrants and Barriers to Market Entry
    Table 41. Split Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 42. Global Split Influenza Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 43. Global Split Influenza Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 44. Global Split Influenza Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 45. Global Split Influenza Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 46. Global Split Influenza Vaccine Average Price by Region (2019-2024) & (US$/Unit)
    Table 47. Global Split Influenza Vaccine Average Price by Region (2025-2030) & (US$/Unit)
    Table 48. Global Split Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 49. Global Split Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 50. Global Split Influenza Vaccine Consumption Value by Type (2019-2024) & (USD Million)
    Table 51. Global Split Influenza Vaccine Consumption Value by Type (2025-2030) & (USD Million)
    Table 52. Global Split Influenza Vaccine Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. Global Split Influenza Vaccine Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. Global Split Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 55. Global Split Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 56. Global Split Influenza Vaccine Consumption Value by Application (2019-2024) & (USD Million)
    Table 57. Global Split Influenza Vaccine Consumption Value by Application (2025-2030) & (USD Million)
    Table 58. Global Split Influenza Vaccine Average Price by Application (2019-2024) & (US$/Unit)
    Table 59. Global Split Influenza Vaccine Average Price by Application (2025-2030) & (US$/Unit)
    Table 60. North America Split Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 61. North America Split Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 62. North America Split Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 63. North America Split Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 64. North America Split Influenza Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 65. North America Split Influenza Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 66. North America Split Influenza Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 67. North America Split Influenza Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 68. Europe Split Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 69. Europe Split Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 70. Europe Split Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 71. Europe Split Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 72. Europe Split Influenza Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 73. Europe Split Influenza Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 74. Europe Split Influenza Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 75. Europe Split Influenza Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 76. Asia-Pacific Split Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 77. Asia-Pacific Split Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 78. Asia-Pacific Split Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 79. Asia-Pacific Split Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 80. Asia-Pacific Split Influenza Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 81. Asia-Pacific Split Influenza Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 82. Asia-Pacific Split Influenza Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 83. Asia-Pacific Split Influenza Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 84. South America Split Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 85. South America Split Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 86. South America Split Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 87. South America Split Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 88. South America Split Influenza Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 89. South America Split Influenza Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 90. South America Split Influenza Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 91. South America Split Influenza Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 92. Middle East & Africa Split Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 93. Middle East & Africa Split Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 94. Middle East & Africa Split Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 95. Middle East & Africa Split Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 96. Middle East & Africa Split Influenza Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 97. Middle East & Africa Split Influenza Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 98. Middle East & Africa Split Influenza Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 99. Middle East & Africa Split Influenza Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 100. Split Influenza Vaccine Raw Material
    Table 101. Key Manufacturers of Split Influenza Vaccine Raw Materials
    Table 102. Split Influenza Vaccine Typical Distributors
    Table 103. Split Influenza Vaccine Typical Customers
List of Figures
    Figure 1. Split Influenza Vaccine Picture
    Figure 2. Global Split Influenza Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Split Influenza Vaccine Consumption Value Market Share by Type in 2023
    Figure 4. Aldult Examples
    Figure 5. Child Examples
    Figure 6. Global Split Influenza Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Split Influenza Vaccine Consumption Value Market Share by Application in 2023
    Figure 8. Hospital Examples
    Figure 9. Clinic Examples
    Figure 10. Global Split Influenza Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Split Influenza Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Split Influenza Vaccine Sales Quantity (2019-2030) & (K Units)
    Figure 13. Global Split Influenza Vaccine Average Price (2019-2030) & (US$/Unit)
    Figure 14. Global Split Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Split Influenza Vaccine Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Split Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Split Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Split Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Split Influenza Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Split Influenza Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Split Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Split Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Split Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Split Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Split Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Split Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Split Influenza Vaccine Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Split Influenza Vaccine Average Price by Type (2019-2030) & (US$/Unit)
    Figure 29. Global Split Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Split Influenza Vaccine Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Split Influenza Vaccine Average Price by Application (2019-2030) & (US$/Unit)
    Figure 32. North America Split Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Split Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Split Influenza Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Split Influenza Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Split Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Split Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Split Influenza Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Split Influenza Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Split Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Split Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Split Influenza Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Split Influenza Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Split Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Split Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Split Influenza Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Split Influenza Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Split Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Split Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Split Influenza Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Split Influenza Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Split Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Split Influenza Vaccine Market Drivers
    Figure 73. Split Influenza Vaccine Market Restraints
    Figure 74. Split Influenza Vaccine Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Split Influenza Vaccine in 2023
    Figure 77. Manufacturing Process Analysis of Split Influenza Vaccine
    Figure 78. Split Influenza Vaccine Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Sanofi Pasteur
CSL Seqirus
GSK
Seqirus, Inc.
straZeneca
Dalian Yali Peak